A detailed history of Guggenheim Capital LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 36,390 shares of LEGN stock, worth $1.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,390
Previous 33,360 9.08%
Holding current value
$1.46 Million
Previous $1.87 Million 13.9%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $119,685 - $173,376
3,030 Added 9.08%
36,390 $1.61 Million
Q1 2024

May 14, 2024

BUY
$55.06 - $69.99 $95,363 - $121,222
1,732 Added 5.48%
33,360 $1.87 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $1.81 Million - $2.21 Million
31,628 New
31,628 $1.9 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.